Variant report

Variant	nsv906747
Chromosome Location	chr16:59385832-60172030
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1632)
CpG islands
(count:919)
Chromatin interactive
region (count:33)
LncRNA
region (count:19)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1632 , 50 per page) page: 1 2 3 4 5 6 7 ... 33

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr16:59390375-59391138	K562	blood:	n/a	n/a
2	ARID3A	chr16:59392455-59392495	K562	blood:	n/a	n/a
3	ATF1	chr16:59552701-59552977	K562	blood:	n/a	n/a
4	ATF1	chr16:59512519-59513106	K562	blood:	n/a	n/a
5	ATF1	chr16:59418654-59418858	K562	blood:	n/a	n/a
6	ATF1	chr16:59574603-59574647	K562	blood:	n/a	n/a
7	ATF1	chr16:59390559-59391019	K562	blood:	n/a	n/a
8	ATF1	chr16:59894857-59895035	K562	blood:	n/a	n/a
9	ATF3	chr16:59390611-59390910	K562	blood:	n/a	n/a
10	ATF3	chr16:59607286-59608197	A549	lung:	n/a	chr16:59607669-59607680 chr16:59607669-59607680 chr16:59607671-59607679 chr16:59607669-59607682
11	ATF3	chr16:59607268-59608238	A549	lung:	n/a	chr16:59607669-59607680 chr16:59607669-59607680 chr16:59607671-59607679 chr16:59607669-59607682
12	BACH1	chr16:59459499-59459576	K562	blood:	n/a	n/a
13	BACH1	chr16:59637252-59637310	H1-hESC	embryonic stem cell:	n/a	n/a
14	BACH1	chr16:59390770-59390783	K562	blood:	n/a	n/a
15	BCL3	chr16:59939444-59939928	A549	lung:	n/a	n/a
16	BCL3	chr16:59607280-59608220	A549	lung:	n/a	chr16:59607950-59607959
17	BCL3	chr16:59607250-59608289	A549	lung:	n/a	chr16:59607950-59607959
18	BCL3	chr16:59561024-59561679	A549	lung:	n/a	n/a
19	BHLHE40	chr16:59390614-59391020	K562	blood:	n/a	n/a
20	CBX3	chr16:59390599-59391070	K562	blood:	n/a	n/a
21	CCNT2	chr16:59390339-59391032	K562	blood:	n/a	n/a
22	CEBPB	chr16:59607839-59608171	A549	lung:	n/a	n/a
23	CEBPB	chr16:59823468-59823509	HepG2	liver:	n/a	chr16:59823484-59823495
24	CEBPB	chr16:59503917-59504195	IMR90	lung:	n/a	chr16:59504092-59504105 chr16:59504092-59504105 chr16:59504092-59504105 chr16:59504092-59504103 chr16:59504094-59504105
25	CEBPB	chr16:59445890-59446220	A549	lung:	n/a	chr16:59446020-59446033
26	CEBPB	chr16:59993030-59993239	HepG2	liver:	n/a	chr16:59993119-59993130 chr16:59993121-59993132
27	CEBPB	chr16:59728890-59729203	IMR90	lung:	n/a	chr16:59729056-59729067
28	CEBPB	chr16:59614762-59614870	A549	lung:	n/a	n/a
29	CEBPB	chr16:59558773-59559102	HepG2	liver:	n/a	chr16:59558913-59558924 chr16:59558913-59558926 chr16:59558913-59558926 chr16:59558914-59558925 chr16:59558913-59558926
30	CEBPB	chr16:59893914-59894223	H1-hESC	embryonic stem cell:	n/a	chr16:59894063-59894074
31	CEBPB	chr16:59702500-59702739	IMR90	lung:	n/a	chr16:59702597-59702608
32	CEBPB	chr16:59402515-59402860	K562	blood:	n/a	chr16:59402685-59402696
33	CEBPB	chr16:59509576-59509726	HepG2	liver:	n/a	chr16:59509680-59509691
34	CEBPB	chr16:60030793-60030993	A549	lung:	n/a	n/a
35	CEBPB	chr16:59752926-59753295	IMR90	lung:	n/a	chr16:59753078-59753089
36	CEBPB	chr16:59639640-59639961	HepG2	liver:	n/a	chr16:59639776-59639787 chr16:59639806-59639817
37	CEBPB	chr16:59699603-59699905	HepG2	liver:	n/a	chr16:59699727-59699740 chr16:59699728-59699739 chr16:59699729-59699738
38	CEBPB	chr16:59939501-59939979	A549	lung:	n/a	n/a
39	CEBPB	chr16:60092372-60092690	HepG2	liver:	n/a	chr16:60092529-60092540 chr16:60092528-60092541
40	CEBPB	chr16:59850016-59850164	H1-hESC	embryonic stem cell:	n/a	chr16:59850074-59850085
41	CEBPB	chr16:60030782-60031054	HepG2	liver:	n/a	n/a
42	CEBPB	chr16:59401576-59401860	HepG2	liver:	n/a	n/a
43	CEBPB	chr16:59702527-59702671	HepG2	liver:	n/a	chr16:59702597-59702608
44	CEBPB	chr16:59775830-59776089	A549	lung:	n/a	chr16:59775920-59775933
45	CEBPB	chr16:59977383-59977548	HepG2	liver:	n/a	n/a
46	CEBPB	chr16:59893879-59894262	A549	lung:	n/a	chr16:59894063-59894074
47	CEBPB	chr16:59933871-59934182	A549	lung:	n/a	chr16:59934003-59934014
48	CEBPB	chr16:59410393-59410398	HepG2	liver:	n/a	n/a
49	CEBPB	chr16:59914476-59914696	A549	lung:	n/a	n/a
50	CEBPB	chr16:59732911-59733165	HepG2	liver:	n/a	n/a

(count:919 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr16:59627519-59627569	GM19239	blood:	n/a
2	chr16:59786279-59786329	SKMC	muscle:	n/a
3	chr16:59786279-59786329	GM06990	blood:	n/a
4	chr16:59789219-59789269	AG09319	gingival:	n/a
5	chr16:59627519-59627569	GM19239	blood:	n/a
6	chr16:59786279-59786329	SKMC	muscle:	n/a
7	chr16:59786279-59786329	GM06990	blood:	n/a
8	chr16:59789219-59789269	AG09319	gingival:	n/a
9	chr16:59788728-59788778	MCF10A-Er-Src	breast:	n/a
10	chr16:59789071-59789121	U87	brain:	n/a
11	chr16:59792836-59792886	HCT-116	colon:	n/a
12	chr16:59792836-59792886	HRCEpiC	kidney:	n/a
13	chr16:59789030-59789080	AoSMC	blood vessel:	n/a
14	chr16:59788728-59788778	HUVEC	blood vessel:	n/a
15	chr16:59789485-59789535	GM12891	blood:	n/a
16	chr16:59792836-59792886	HUVEC	blood vessel:	n/a
17	chr16:59788951-59789001	GM12892	blood:	n/a
18	chr16:59786279-59786329	HRE	kidney:	n/a
19	chr16:59789219-59789269	HEEpiC	esophagus:	n/a
20	chr16:59789030-59789080	SK-N-MC	brain:	n/a
21	chr16:59788951-59789001	PrEC	prostate:	n/a
22	chr16:59789071-59789121	HCT-116	colon:	n/a
23	chr16:59789030-59789080	SK-N-SH	brain:	n/a
24	chr16:59789071-59789121	NT2-D1	testis:	n/a
25	chr16:60010823-60010873	AG09309	skin:	n/a
26	chr16:59788951-59789001	SKMC	muscle:	n/a
27	chr16:59789485-59789535	HRPEpiC	eye:	n/a
28	chr16:59788951-59789001	HRPEpiC	eye:	n/a
29	chr16:59656293-59656343	U87	brain:	n/a
30	chr16:59602460-59602510	GM06990	blood:	n/a
31	chr16:59627519-59627569	GM12891	blood:	n/a
32	chr16:59789030-59789080	T-47D	breast:	n/a
33	chr16:59789030-59789080	AG04450	lung:	fetal
34	chr16:59788951-59789001	ECC-1	luminal epithelium:	n/a
35	chr16:59789485-59789535	HRCEpiC	kidney:	n/a
36	chr16:59789071-59789121	HEK293	kidney:	embryo
37	chr16:59789030-59789080	GM19239	blood:	n/a
38	chr16:59788728-59788778	NHBE	bronchial:	n/a
39	chr16:59789071-59789121	MCF10A-Er-Src	breast:	n/a
40	chr16:59790082-59790132	GM12878	blood:	n/a
41	chr16:59627519-59627569	HEEpiC	esophagus:	n/a
42	chr16:60010823-60010873	ovcar-3	ovarian:	n/a
43	chr16:59602460-59602510	GM12878	blood:	n/a
44	chr16:59786279-59786329	AoSMC	blood vessel:	n/a
45	chr16:60010823-60010873	T-47D	breast:	n/a
46	chr16:59789071-59789121	HIPEpiC	eye:	n/a
47	chr16:59789071-59789121	ProgFib	skin:	n/a
48	chr16:60010823-60010873	GM12891	blood:	n/a
49	chr16:60010823-60010873	Hepatocyte	liver:	n/a
50	chr16:59788951-59789001	HRCEpiC	kidney:	n/a

(count:33 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr16:59973167..59974731-chr16:60006878..60009430,2	MCF-7	breast:
2	chr16:60121893..60124801-chr16:60126777..60128433,2	MCF-7	breast:
3	chr16:59388705..59390354-chr16:59392227..59393861,2	K562	blood:
4	chr16:59802014..59804199-chr16:59814012..59816551,2	K562	blood:
5	chr16:59710678..59713121-chr16:59778438..59780009,2	K562	blood:
6	chr16:59944781..59947331-chr16:59948422..59950704,2	MCF-7	breast:
7	chr16:59581382..59583967-chr16:59590690..59593280,2	MCF-7	breast:
8	chr16:60133611..60135884-chr16:60236777..60239075,2	K562	blood:
9	chr16:59581382..59583967-chr16:59590690..59593280,2	MCF-7	breast:
10	chr16:59710678..59713121-chr16:59778438..59780009,2	K562	blood:
11	chr16:59802014..59804199-chr16:59814012..59816551,2	K562	blood:
12	chr16:59730238..59732939-chr3:97563003..97565712,2	MCF-7	breast:
13	chr16:59962673..59964307-chr16:59966390..59968142,2	K562	blood:
14	chr16:59772981..59773721-chrX:108093803..108094584,2	HCT-116	colon:
15	chr16:59388705..59390354-chr16:59392227..59393861,2	K562	blood:
16	chr16:59519600..59521428-chr16:59529672..59531937,2	K562	blood:
17	chr16:59464240..59466061-chr16:59467687..59469793,2	K562	blood:
18	chr16:59944781..59947331-chr16:59948422..59950704,2	MCF-7	breast:
19	chr16:60004466..60006529-chr5:21480625..21483296,2	MCF-7	breast:
20	chr16:59962673..59964307-chr16:59966390..59968142,2	K562	blood:
21	chr16:59909180..59912142-chr16:59912804..59915333,2	K562	blood:
22	chr16:59390555..59392761-chr16:59393637..59395380,2	K562	blood:
23	chr16:59390555..59392761-chr16:59393637..59395380,2	K562	blood:
24	chr16:59635524..59637585-chr16:59638803..59640976,2	K562	blood:
25	chr16:59445008..59446636-chr16:59454260..59456592,2	K562	blood:
26	chr16:59909180..59912142-chr16:59912804..59915333,2	K562	blood:
27	chr16:59635524..59637585-chr16:59638803..59640976,2	K562	blood:
28	chr16:59519600..59521428-chr16:59529672..59531937,2	K562	blood:
29	chr16:60121893..60124801-chr16:60126777..60128433,2	MCF-7	breast:
30	chr16:59445008..59446636-chr16:59454260..59456592,2	K562	blood:
31	chr16:59973167..59974731-chr16:60006878..60009430,2	MCF-7	breast:
32	chr16:59464240..59466061-chr16:59467687..59469793,2	K562	blood:
33	chr16:60023642..60024389-chr17:54895894..54896686,2	MCF-7	breast:

(count:19 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RP11-105C20.2.1-2	chr16:59438650-59438797	XLOC_011971
2	lnc-SETD6-13	chr16:59689506-59689824	NONHSAT142891
3	lnc-RP11-105C20.2.1-5	chr16:59788689-59788752	NONHSAT142892
4	lnc-RP11-105C20.2.1-5	chr16:59788365-59788930	NONHSAT142894
5	lnc-RP11-105C20.2.1-5	chr16:59743897-59744027	NONHSAT142892
6	lnc-RP11-105C20.2.1-5	chr16:59744120-59744199	NONHSAT142892
7	lnc-SETD6-2	chr16:60078615-60078703	ENSG00000261807.1
8	lnc-RP11-105C20.2.1-5	chr16:59788045-59789095	NONHSAT142893
9	lnc-RP11-105C20.2.1-1	chr16:59497608-59497658	XLOC_011972
10	lnc-RP11-105C20.2.1-2	chr16:59445379-59445573	XLOC_011971
11	lnc-SETD6-13	chr16:59690034-59690240	NONHSAT142891
12	lnc-SETD6-2	chr16:60081759-60087875	ENSG00000261807.1
13	lnc-RP11-105C20.2.1-1	chr16:59475882-59476136	XLOC_011972
14	lnc-SETD6-2	chr16:60080132-60080336	ENSG00000261807.1
15	lnc-RP11-105C20.2.1-6	chr16:60058482-60058808	NONHSAT142896
16	lnc-RP11-105C20.2.1-6	chr16:60058947-60059045	NONHSAT142896
17	lnc-RP11-105C20.2.1-5	chr16:59785865-59785999	NONHSAT142892
18	lnc-RP11-105C20.2.1-2	chr16:59436484-59436576	XLOC_011971
19	lnc-SETD6-2	chr16:59889257-59889429	ENSG00000261807.1

No data

Variant related genes	Relation type
RNU4-58P	TF binding region
ENSG00000260240	TF binding region
ENSG00000238601	TF binding region
APOOP5	TF binding region
ENSG00000261807	TF binding region
ENSG00000270222	TF binding region
ENSG00000261278	TF binding region
RNU4-58P	CpG island
ENSG00000260240	CpG island
ENSG00000238601	CpG island
APOOP5	CpG island
ENSG00000261807	CpG island
ENSG00000270222	CpG island
ENSG00000261278	CpG island
KIAA1549	miRNA target sites
KIAA1586	miRNA target sites

Extended variants
information (count: 17695 )
Associated
traits (count: 78 )

Variant overlapped rSNPs/rCNVs (count:17695 , 50 per page) page: 1 2 3 4 5 6 7 ... 354

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs531387654	chr16:59389016-59389017	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs549710449	chr16:59389027-59389028	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs571161419	chr16:59389030-59389031	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs111513874	chr16:59389097-59389098	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs531928045	chr16:59389120-59389121	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs543969484	chr16:59389125-59389126	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs58815015	chr16:59389126-59389127	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs397706563	chr16:59389132-59389133	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs531989636	chr16:59389136-59389137	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs547333253	chr16:59389159-59389160	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs113572593	chr16:59389213-59389214	Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
12	rs536372244	chr16:59389225-59389226	Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
13	rs554349314	chr16:59389232-59389233	Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
14	rs371143279	chr16:59389240-59389241	Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
15	rs2113220	chr16:59389266-59389267	Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
16	rs565735792	chr16:59389276-59389277	Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
17	rs77152375	chr16:59389301-59389302	Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
18	rs568658151	chr16:59389335-59389336	Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
19	rs72788254	chr16:59389420-59389421	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs367731731	chr16:59389464-59389465	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs57452945	chr16:59389468-59389469	Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs554109124	chr16:59389492-59389493	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs569896048	chr16:59389509-59389510	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs557856518	chr16:59389534-59389535	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs558694105	chr16:59389537-59389538	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs374035660	chr16:59389638-59389639	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs543142796	chr16:59389688-59389689	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs561216472	chr16:59389713-59389714	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs186196632	chr16:59389722-59389723	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs189433825	chr16:59389782-59389783	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs564849741	chr16:59389827-59389828	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs181953463	chr16:59389916-59389917	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs115688580	chr16:59389940-59389941	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs567811514	chr16:59390023-59390024	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs575331986	chr16:59390069-59390070	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs559333259	chr16:59390087-59390088	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs529644549	chr16:59390098-59390099	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs368250204	chr16:59390107-59390108	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs142412972	chr16:59390127-59390128	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs569723138	chr16:59390142-59390143	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs368454005	chr16:59390195-59390196	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs34387630	chr16:59390201-59390202	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs550364876	chr16:59390215-59390216	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs151316143	chr16:59390233-59390234	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs141863617	chr16:59390239-59390240	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs554154827	chr16:59390255-59390256	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs71400070	chr16:59390259-59390260	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs536205157	chr16:59390265-59390266	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs191919692	chr16:59390278-59390279	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs576092381	chr16:59390286-59390287	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:78)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16702952	CNVD
Medulloblastoma	16968546	CNVD
Prostate cancer	19242612	CNVD
Cancer	22429812	CNVD
Ewing''s sarcoma	21437220	CNVD
Ewing''s sarcoma	22429812	CNVD
Melanoma	18172304	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Multiple myeloma	21628407	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Breast cancer	21364760	CNVD
Ewing''s sarcoma	17952124	CNVD
Bladder cancer	21909424	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Infertility	21528002	CNVD
Breast cancer	21806811	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Prostate cancer	16573809	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Cancer	21183584	CNVD
Ovarian cancer	20844748	CNVD
Neurodevelopmental disorder	22521361	CNVD
Glioblastoma multiforme	22286061	CNVD
Autism	18414403	CNVD
Breast cancer	20409316	CNVD
Chordoma	18071362	CNVD
Prostate cancer	17245344	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Ovarian cancer	21720365	CNVD
Leiomyosarcoma	16982739	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Autism	20972252	CNVD
Invasive breast cancer	20972252	CNVD
Breast cancer	17142309	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Breast cancer	22522925	CNVD
Autism	20531469	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Autism	18522746	CNVD

Chromatin state (count:1209 , 50 per page) page: 1 2 3 4 5 6 7 ... 25

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:59389000-59391200	Enhancers	HUES48 Cell Line	embryonic stem cell
2	chr16:59389000-59391200	Enhancers	iPS-18 Cell Line	embryonic stem cell
3	chr16:59389200-59389400	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
4	chr16:59389200-59389800	Enhancers	ES-I3 Cell Line	embryonic stem cell
5	chr16:59389200-59390400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
6	chr16:59389200-59391000	Enhancers	HUES64 Cell Line	embryonic stem cell
7	chr16:59389200-59391200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
8	chr16:59389400-59389600	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
9	chr16:59389400-59390000	Enhancers	H9 Cell Line	embryonic stem cell
10	chr16:59389400-59390000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
11	chr16:59389400-59390800	Enhancers	iPS-15b Cell Line	embryonic stem cell
12	chr16:59389400-59391000	Enhancers	H1 Cell Line	embryonic stem cell
13	chr16:59389400-59391000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
14	chr16:59389400-59391400	Enhancers	HUES6 Cell Line	embryonic stem cell
15	chr16:59389600-59389800	Active TSS	iPS-20b Cell Line	embryonic stem cell
16	chr16:59389600-59392000	Enhancers	K562	blood
17	chr16:59389800-59390000	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
18	chr16:59389800-59390800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
19	chr16:59390000-59390400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
20	chr16:59390000-59391200	Enhancers	iPS-20b Cell Line	embryonic stem cell
21	chr16:59390400-59390800	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
22	chr16:59390400-59391600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
23	chr16:59390600-59392000	Enhancers	A549	lung
24	chr16:59390800-59391200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
25	chr16:59390800-59392000	Enhancers	Stomach Mucosa	stomach
26	chr16:59391000-59396200	Weak transcription	H1 Cell Line	embryonic stem cell
27	chr16:59396200-59396600	ZNF genes & repeats	H1 Cell Line	embryonic stem cell
28	chr16:59399800-59400600	Enhancers	A549	lung
29	chr16:59400200-59401600	Enhancers	Breast Myoepithelial Primary Cells	Breast
30	chr16:59400600-59401600	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
31	chr16:59400600-59401600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
32	chr16:59400600-59404600	Weak transcription	A549	lung
33	chr16:59401800-59402600	Enhancers	HUES48 Cell Line	embryonic stem cell
34	chr16:59401800-59402600	Enhancers	HUES6 Cell Line	embryonic stem cell
35	chr16:59401800-59402600	Enhancers	iPS-15b Cell Line	embryonic stem cell
36	chr16:59401800-59402800	Enhancers	iPS-18 Cell Line	embryonic stem cell
37	chr16:59402000-59402600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
38	chr16:59402000-59403000	Enhancers	HUES64 Cell Line	embryonic stem cell
39	chr16:59402600-59402800	Enhancers	H1 Cell Line	embryonic stem cell
40	chr16:59402600-59403000	Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
41	chr16:59402600-59403600	Weak transcription	HUES48 Cell Line	embryonic stem cell
42	chr16:59402800-59403200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
43	chr16:59403000-59403400	Weak transcription	HUES64 Cell Line	embryonic stem cell
44	chr16:59403200-59403800	Enhancers	iPS-18 Cell Line	embryonic stem cell
45	chr16:59403400-59403600	Enhancers	H1 Cell Line	embryonic stem cell
46	chr16:59403400-59403800	Enhancers	HUES64 Cell Line	embryonic stem cell
47	chr16:59403600-59403800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
48	chr16:59403600-59403800	Enhancers	HUES48 Cell Line	embryonic stem cell
49	chr16:59404600-59405000	Enhancers	A549	lung
50	chr16:59404600-59405400	Enhancers	Liver	Liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links